Navigation Links
CEL-SCI Takes Delivery of New Manufacturing Facility
Date:10/9/2008

VIENNA, Va., Oct. 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE: CVM) announced today that it has taken delivery of the new manufacturing facility for its lead drug Multikine(R). This dedicated facility, located in the Baltimore area, will produce the Multikine that will be used for CEL-SCI's pivotal Phase III clinical trial for first-line therapy of previously untreated head and neck cancer patients, and subsequently for sale following approval of the drug. The facility, which cost about $22 million to build, is state of the art and will soon be commercial ready. As it stands today, the facility can produce about $600 million worth of drug per year. Within one year it can be built out to product almost $2 billion worth of drug per year.

Geert Kersten, CEL-SCI's Chief Executive Officer said, "Multikine started with the idea that activating the immune system to fight cancer could be beneficial and successful, as long as you could activate the immune system before it was weakened by surgery, radiation and chemotherapy. Our clinical studies showed significant benefit to the cancer patients treated with Multikine. We are now in the home stretch. Having our own Multikine dedicated manufacturing facility gives us control and eliminates a great deal of risk from our product development. Our next step is to completely validate the facility and to bring it on line for manufacturing."

CEL-SCI is developing Multikine for approval as a first line indication in head and neck cancer. To that end, the Company's upcoming Phase III clinical trial is an 800 patient clinical study designed to demonstrate that administration of its cancer drug Multikine to head and neck cancer patients before they receive any conventional cancer treatmen
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. CEL-SCI to Present at the Noble Financial Conference
2. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
3. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
4. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
5. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
6. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
7. First European IGRT School Takes Place for Radiotherapy Practitioners in UK
8. Ground-Breaking Conference Takes on Abortion
9. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
10. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
11. Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
...IS, Dec. 8 A new initiative announced,today aims ...United States,largest river system, the Mississipp...cultural and conservation groups that are working ...sippi River into the Gulf of Mexico. , The N...d Delta Wildlife,are all working collaboratively w...
...A BEACH, Va., Dec. 8 LifeNet Health, a leading al...tiGraft Tendon and the Triple Bunch Tendon, both o..., , LifeNet Health,s new bio-medical implants...ive in repairing patient injuries. KinetiGraft Ten...onstruction of either the anterior or posterior cr...
... CITY, Calif., Dec. 8 Genomic Health,Inc. (Nasdaq...er L. Graham to its,board of directors. Ms. Graha...ceuticals, Inc.; a biopharmaceutical company dedic... the lives of people with diabetes and obesity.,Pr..., Office of the President,for Guidant Corporation,...
Other Biology Technology:New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico 2New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico 3New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico 4New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico 5New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico 6New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico 7LifeNet Health Introduces New Sports Medicine Bio-Implants 2Genomic Health Announces Appointment of Ginger Graham to Board of Directors 2Genomic Health Announces Appointment of Ginger Graham to Board of Directors 3
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Simon Eye Associates Donates to 26quot 3BUnite For Sight 26quot 3B Efforts in Ghana 55095 1Simon Eye Associates Donates to 26quot 3BUnite For Sight 26quot 3B Efforts in Ghana 55095 2FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone 55093 1FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone 55093 2FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone 55093 3Young leukemia and lymphoma patients live longer today than in years past 55090 1Young leukemia and lymphoma patients live longer today than in years past 55090 2
... and start living more sustainably to save the env...good. , So say an environmental scientist and an ...he March 2009 issue of the international journal, ...or of animal ecology at Michigan Technological Uni...f environmental ethics at Michigan State Universit...
...ch offers a revolutionary new model for Alzheimer,...sorder which afflicts 24 million people worldwide.... protein implicated in AD, scientists in Californi... protein that provides a new therapeutic target fo...ry that AD is a disease of toxicity stemming from ...
... stressed fish do it. But Prof. Yossi Loya from Te...irst in the world to discover that Japanese sea co...h may provide the key to the survival of fragile s...an ― currently threatened by global warming....he female mushroom coral (known as a fungiid coral...
Other Biology News:Abandon hope 2A revolutionary new model for Alzheimer's disease 2Changing sexes on the sea floor 2
...f small interfering RNA (siRNA) molecules to silen... pathway have generated tremendous interest in the...experimental use can be,synthesized in vitro, eith...ed into the target cells in vitro or in vivo [1-4]...
...sion reaction interface (CRI) system*, which provi...scopic interferences. The result is faster, more f...ry of complex multipole or scanning quadrupole ion...all instrument parameters, including CRI gases, in...
...ur samples with eArray and Agilents custom printin...reate your own microarray designs that meet your s...and receive delivery of your arrays in weeks, anyw...y creation application tool that enables you to de...
...200L sets the new standard for value in today's co...t technologies and providing tailored solutions fo... Atmospheric Pressure Ionization (API) interface a...perior selectivity and sensitivity for pharmaceuti...
Biology Products: